retatrutide clinical trial results weight loss 2024 2025 press release Retatrutide—A Game Changer in Obesity Pharmacotherapy Incretin-based therapies for the treatment

*Clinical studies show patients treated with GLP-1s experienced an average weight loss of 14.9-20.9% of their total body weight after 68-72 weeks

When energy is unstable, calories are low, sleep is disrupted, or stress is elevated, the brain can interpret that state as scarcity

If youre ready to pair smart, protein-forward eating with a carefully supervised GLP-1 protocol, you can explore Nuris Body Recomposition Program featuring Retatrutide

Do long-term side effects accumulate

When to talk to a healthcare provider Only take GLP-1s alongside the guidance of a healthcare provider, and with regular touchpoints where you can talk to that provider about your symptoms